In terms of clinical trials, due to the long-standing controversy over the therapeutic benefit versus the risk of adverse effect of corticosteroids in diabetes associated kidney diseases, very few have been done to evaluate the effect of ACTH in DN. The gene discussed is POMC; the disease is kidney disorder.